| Literature DB >> 31632993 |
Sean McMillan1, Anikar Chhabra2, Jeffrey D Hassebrock2, Elizabeth Ford1, Nirav H Amin3.
Abstract
BACKGROUND: Classically, arthroscopy has been considered one of the diagnostic gold standards for assessing intra-articular knee and shoulder abnormality.Entities:
Keywords: Outpatient; clinic; diagnostic arthroscopy; needle arthroscopy
Year: 2019 PMID: 31632993 PMCID: PMC6767734 DOI: 10.1177/2325967119869846
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.The Mi-Eye2 system.
Major and Minor Complications as Defined by the 13 Participating Physicians
| Major Complication | Minor Complication |
|---|---|
| Infection | Vasovagal episode |
| Chondrotoxicity | Pain lasting >24 h or requiring narcotics |
| Need for emergency department or urgent care evaluation | Need for crutches or sling postprocedure Need for MRI postprocedure |
Chondrotoxicity was defined previously in the literature as rapid chondrocyte death and progression of arthritis associated with intra-articular local anesthetic.[7,13] MRI, magnetic resonance imaging.
Figure 2.Example of aseptic preparation of a right knee by use of superolateral, medial, and lateral portal sites with alcohol and Betadine (Avrio Health).
Breakdown of Each Physician’s Mode of Entry Into the Joint, Technique for Closure, and Pre- and Postprocedure Antibiotic Regimens
| Physician No. | Scalpel for Entry | Suture or Glue for Closure | Preprocedure Antibiotics | Postprocedure Antibiotics |
|---|---|---|---|---|
| 1 | N | N | N | N |
| 2 | N | N | N | N |
| 3 | N | N | N | N |
| 4 | N | N | N | N |
| 5 | N | N | N | N |
| 6 | N | N | N | N |
| 7 | N | N | N | N |
| 8 | N | N | N | N |
| 9 | N | N | N | N |
| 10 | N | N | N | N |
| 11 | N | N | N | N |
| 12 | N | N | N | N |
| 13 | N | N | N | N |
N, none given or used.
Sterile Technique, Number of Cases, Anesthetic Preparation, and Infections, Broken Down by Physician and Joint
| Physician No. | Joint | No. of Cases | Standard Sterile Preparation Protocol | Standard Anesthetic Preparation Protocol | Infections |
|---|---|---|---|---|---|
| 1 | Knee | 224 | Betadine swab sticks, then alcohol on sterile gauze for anesthetic, then repeat same for Mi-Eye2. | 10-15 mL of 1% lidocaine for skin and capsule | 0 |
| Shoulder | 116 | 0 | |||
| 2 | Knee | 137 | ChloraPrep | 15 mL total of 1% lidocaine/0.25% Marcaine | 0 |
| Shoulder | 7 | ChloraPrep | 30 mL total of 1% lidocaine/0.25% Marcaine | 0 | |
| 3 | Knee | 7 | ChloraPrep | 1% lidocaine: 5 mL anterolateral, 5 mL anteromedial, 10 mL suprapatellar per joint | 0 |
| Shoulder | 4 | ChloraPrep | 10 mL of 1% lidocaine, posterior approach | 0 | |
| 4 | Knee | 187 | Betadine swab | 10 mL of 1% lidocaine with epinephrine in each portal | 0 |
| Shoulder | 4 | 10 mL of 1% lidocaine with epinephrine in each portal | 0 | ||
| 5 | Knee | 172 | Alcohol and ChloraPrep first (then infiltration tract). Next, cover the site and repeat preparation with ChloraPrep stick (no drapes). | 20-30 mL of 1% lidocaine with 2 mL of bicarbonate | 0 |
| Shoulder | 51 | 20-30 mL of 1% lidocaine with 2 mL of bicarbonate | 0 | ||
| 6 | Knee | 22 | ChloraPrep | 5 mL of 1% lidocaine with epinephrine in each portal | 0 |
| Shoulder | 1 | 5 mL of 1% lidocaine with epinephrine in each portal | 0 | ||
| 7 | Knee | 5 | Gowned first and then preparation with hydrogen peroxide, followed by Betadine. Anesthetic given and allowed to set up for 10 min. Then another Betadine preparation with ethyl chloride for procedure. | 10-15 mL of 1% lidocaine | 0 |
| Shoulder | 82 | 0 | |||
| 8 | Knee | 39 | Chlorhexidine, sterile gloves, no drape. | 10 mL of 1% lidocaine | 0 |
| 9 | Knee | 19 | Betadine swab sticks, then alcohol for Mi-Eye2 needle. | Anesthetic: cold spray, 20 mL of 1% lidocaine without epinephrine in portals and joint | 0 |
| 10 | Knee | 127 | Betadine swab sticks, then alcohol on sterile gauze for anesthetic, then repeat same for Mi-Eye2. | 20 mL total, half lidocaine 1%, half Marcaine 0.25% with epinephrine | 0 |
| Shoulder | 9 | Same as for knee | 0 | ||
| 11 | Knee | 50 | Iodine swab for injection of lidocaine-Marcaine mix followed by ChloraPrep and drape for the procedure. | 0 | |
| Shoulder | 6 | 0 | |||
| 12 | Knee | 56 | Alcohol followed by chlorhexidine preparation for injection, repeat chlorhexidine preparation for procedure, sterile gloves, no drapes. | Initial preparation with cold spray, then 15-20 mL of 1% lidocaine with epinephrine in skin and the track down to capsule; about 5 mL into the joint | 0 |
| Shoulder | 16 | 0 | |||
| 13 | Knee | 74 | ChloraPrep swab, no drape. | 8 mL of 1% lidocaine with epinephrine, 2-3 mL in capsule, minimal amount in joint | 0 |
| Shoulder | 4 | 0 |
Manufacturers: Betadine, Avrio Health; ChloraPrep, Becton Dickinson and Co; Marcaine, Pfizer.
Minor Complications and Patient Positioning, Broken Down by Physician and Joint
| Physician No. | Joint | Cases, n | Standard Patient Positioning | Vasovagal, n | Persistent Pain (>24 h), n | Need for Additional MRI, n |
|---|---|---|---|---|---|---|
| 1 | Knee | 224 | Supine | 3 | 0 | 4 |
| Shoulder | 116 | Lateral | 0 | 0 | 1 | |
| 2 | Knee | 137 | Sitting | 5 | 0 | 2 |
| Shoulder | 7 | Sitting | 0 | 0 | 0 | |
| 3 | Knee | 7 | Supine (knee flexed to 90°, extended, frog-leg standard) | 0 | 0 | 0 |
| Shoulder | 4 | Sitting upright in examination chair | 0 | 0 | 1 | |
| 4 | Knee | 187 | Seated with knee bent | 2 | 0 | 2 |
| Shoulder | 4 | Lateral, holding IV pole | 0 | 0 | 0 | |
| 5 | Knee | 172 | Supine | 0 | 2 | 2 |
| Shoulder | 51 | Beach-chair | 3 | |||
| 6 | Knee | 22 | Supine, then seated with knee bent | 1 | 0 | 0 |
| Shoulder | 1 | Seated | 0 | 0 | 0 | |
| 7 | Knee | 5 | Lateral | 1 | 0 | 0 |
| Shoulder | 82 | Beach-chair | 3 | 0 | 0 | |
| 8 | Knee | 39 | Supine | 1 | 0 | 2 |
| 9 | Knee | 19 | Supine | 1 | 0 | 0 |
| 10 | Knee | 127 | Lying supine with legs flexed at knees, off end of examination table | 2 | 3 | |
| Shoulder | 9 | Sitting upright at end of examination table | 0 | 0 | 0 | |
| 11 | Knee | 50 | Supine | 0 | 0 | 0 |
| Shoulder | 6 | Beach-chair | 2 | 0 | 0 | |
| 12 | Knee | 56 | Seated | 2 | 2, different from vasovagal patients | 0 |
| Shoulder | 16 | Seated | 0 | 0 | ||
| 13 | Knee | 74 | Supine | 0 | 1 | 2 |
| Shoulder | 4 | 2 seated, 2 lateral | 1 | 0 | 1 |
IV, intravenous; MRI, magnetic resonance imaging.